However GI & health performance weaker than predicted
Aviva's life business (up 9% from 2016) performed 6% better than the Goldman Sachs estimate and 5% better than consensus, while GI & health was down (-16%) to £700m (from £833m last year). Life profits were £2,882m for the year (up from £2,642m in 2016) supported by a +£86m benefit (vs £50m last year) from the annuity business's increasing concentration of illiquids within its asset mix and £290m related to longevity assumption changes. The firm said it was encouraged by new business growth...
Income protection decline leaving customers at risk of limited payment policies
Smoking still biggest culprit and obesity second - however only 15% know the latter is connected
As private medical demand increases, so do the challenges regarding storing personal data. Paragon's Mitch Cornelia explores how a specialist provider can supply the security needed in light of GDPR
Due to popular demand, venue and date changed to One Birdcage Walk, Westminster, London on 2 May